Drug repurposing in skeletal muscle ion channelopathies.

Abstract excerpt

Skeletal muscle ion channelopathies are rare genetic diseases mainly characterized by myotonia (muscle stiffness) or periodic paralysis (muscle weakness). Here, we reviewed the available therapeutic options in non-dystrophic myotonias (NDM) and periodic paralyses (PP), which consists essentially in drug repositioning to address stiffness or weakness attacks. Empirical use followed by successful randomized...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Channelopathies
• Share to Drug Repositioning
• Share to Muscle, Skeletal